Mucosal and transdermal vaccine delivery strategies against COVID-19
نویسندگان
چکیده
منابع مشابه
Strategies of vaccine production against COVID-19: when will an effective vaccine be produced?
There is a strong consensus globally that production of an effective vaccine against SARS-CoV-2 is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. In this paper, we review vaccine candidate against COVID-19 and also cha...
متن کاملChitosan-based Nanoparticles in Mucosal Vaccine Delivery
Most infectious diseases are caused by pathogenic infiltrations from the mucosal tract. Nowadays, the use of vaccines has been widely investigated for the prevention of different infectious diseases, infertility, immune disorders, malignancies, and allergies. Broad-spectrum adjuvant substances have been studied for immune system stimulation with a greater efficiency against specific antigens. V...
متن کاملDNA Vaccine Administration Through Transdermal Delivery Systems
Infectious disease is a global problem and it effects almost all sections of peoples. A number of microorganisms are available to cause a variety of diseases. The infectious disease has tremendous impact on human health which has made the life miserable. The basic treatment for the infectious disese is the use of antimicrobials and the use of vaccination. Both of the above methods have the side...
متن کاملEthical Issues in COVID-19 Vaccine Rollout
From the beginning of the COVID-19 pandemic, researchers aspired to produce an effective vaccine with appropriate efficacy and low side effects to mitigate the pandemic. It seems that vaccination is the only mean to save the world from this pandemic. In this article, we will review the ethical challenges of mass vaccination (focusing on the vaccine distribution and uptake), referring to the mai...
متن کاملHelicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Vaccination, especially mucosal vaccination, is considered to be effective in the management of Helicobacter pylori infections. However, most antigens alone cannot induce immune responses when administered mucosally and need to be co-administered with adjuvants or delivery systems. The current research on the mucosal adjuvant and delivery systems of vaccine against H. pylori, including advantag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Delivery and Translational Research
سال: 2021
ISSN: 2190-393X,2190-3948
DOI: 10.1007/s13346-021-01001-9